SCHEMBL4634798

SCHEMBL4634798

COC(=O)N([C]=O)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.44
ALDH1A1 P00352 3/20 0.44
NPSR1 Q6W5P4 2/20 0.44
HPGD P15428 2/20 0.44
MAPT P10636 1/20 0.44
ALOX15 P16050 1/20 0.44
HSD17B10 Q99714 1/20 0.44
TSHR P16473 2/20 0.41
TDP1 Q9NUW8 2/20 0.40
ATM Q13315 1/20 0.40
KMT2A Q03164 4/20 0.39
MEN1 O00255 1/20 0.38
KDM4E B2RXH2 1/20 0.38
KCNN4 O15554 1/20 0.37
GLA P06280 1/20 0.37
CHRM4 P08173 1/20 0.37
CHRM3 P20309 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4633391 0.80 ALDH1A1 (0.48) L3MBTL1ALDH1A1HPGDMAPTHSD17B10
SCHEMBL3239982 0.79 NPSR1 (0.44) L3MBTL1ALDH1A1NPSR1TSHRKMT2A
SCHEMBL4633406 0.78 LMNA (0.49) L3MBTL1ALDH1A1HPGDMAPTHSD17B10
SCHEMBL3664780 0.77 NPSR1 (0.46) L3MBTL1ALDH1A1NPSR1ALOX15TSHR
SCHEMBL6639923 0.77 L3MBTL1 (0.40) L3MBTL1ALDH1A1NPSR1HPGDHSD17B10
SCHEMBL7663072 0.77 NPSR1 (0.39) L3MBTL1ALDH1A1NPSR1HPGDTSHR
SCHEMBL27417645 0.77 OPRM1 (0.40) ALDH1A1NPSR1HPGDMAPTHSD17B10
SCHEMBL7663064 0.76 MTNR1A (0.37) ALDH1A1HPGDTSHRKMT2AMEN1
SCHEMBL5696331 0.75 L3MBTL1 (0.49) L3MBTL1ALDH1A1NPSR1HPGDMAPT
SCHEMBL3276086 0.75 L3MBTL1 (0.61) L3MBTL1ALDH1A1NPSR1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0334014-A2 Substitued imidazolinones and imidazolethiones BAYER AG (DE) 1989-09-27 EP claimed
EP-0287890-A1 Substituted pyrroles BAYER AG (DE) 1988-10-26 EP claimed
US-20230150951-A1 2,5- OR 2,6-DISUBSTITUTED HYDROQUINONE DERIVATIVES WITH AT LEAST ONE CARBOXY, SULFO OR AMIDO GROUP USEFUL AS MEDICAMENTS OM PHARMA SA (CH) 2023-05-18 US disclosed
US-7405030-B2 Imide compound and optical recording media made by using the same MITSUI CHEMICALS, INC. (JP) 2008-07-29 US disclosed
EP-1930339-A2 Imide compound MITSUI CHEMICALS, INC. (JP) 2008-06-11 EP disclosed
US-20070259151-A1 Imide compound and optical recording media made by using the same MITSUI CHEMICALS, INC. (JP) 2007-11-08 US disclosed
US-7259260-B2 Imide compound and optical recording media made by using the same MITSUI CHEMICALS, INC. (JP) 2007-08-21 US disclosed
EP-1247655-B1 OPTICAL RECORDING MEDIUM AND NOVEL AZAPORPHYRIN COMPOUNDS MITSUI CHEMICALS INC (JP) 2006-05-31 EP disclosed
US-20060088786-A1 Rewritable optical information recording medium, recording and reproducing methods, as well as recording and reproducing apparatus MITSUI CHEMICALS, INC. (JP) 2006-04-27 US disclosed
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
EP-1262966-B1 Optical recording medium and novel azaporphyrin compound MITSUI CHEMICALS INC (JP) 2006-04-12 EP disclosed
US-20030194646-A1 Mono-, di-, and triazaporphyrin compounds optionally in the form of a metal or metalloid complex MITSUI CHEMICALS, INC. (JP) 2003-10-16 US disclosed
US-6627288-B1 Optical recording medium and porphycene compound MITSUI CHEMICALS, INC. (JP) 2003-09-30 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed
EP-1262966-A2 Optical recording medium and novel azaporphyrin compound Mitsui Chemicals, Inc. (JP) 2002-12-04 EP disclosed
EP-1247655-A1 OPTICAL RECORDING MEDIUM AND NOVEL AZAPORPHYRIN COMPOUNDS Mitsui Chemicals, Inc. (JP) 2002-10-09 EP disclosed
EP-1180765-A1 Optical recording medium and porphycene compound Mitsui Chemicals, Inc. (JP) 2002-02-20 EP disclosed
US-4414225-A Azepine derivatives and their anti-thrombotic compositions and methods DR. KARL THOMAE GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1983-11-08 US disclosed
EP-0058341-A1 Azepine derivatives, their preparation and medicaments containing them Dr. Karl Thomae GmbH (DE) 1982-08-25 EP disclosed
US-4052371-A AZO PIGMENT OR DYE HAVING A NAPHTHYL-QUINAZALONE COUPLING COMPONENT BASF AKTIENGESELLSCHAFT (DT) 1977-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150951-A1 2,5- OR 2,6-DISUBSTITUTED HYDROQUINONE DERIVATIVES WITH AT LEAST ONE CARBOXY, SULFO OR AMIDO GROUP USEFUL AS MEDICAMENTS HRH4, NCOA4, HRH3 L3MBTL1 3464/4885ALDH1A1 3025/4885NPSR1 663/4885
US-20060088786-A1 Rewritable optical information recording medium, recording and reproducing methods, as well as recording and reproducing apparatus ALPG, TRPC6, GNRHR L3MBTL1 1083/4885ALDH1A1 2071/4885NPSR1 2002/4885
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR L3MBTL1 2718/4885ALDH1A1 1045/4885NPSR1 2939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.